In earlier studies, oncogenic EGFR signaling upregulated PD-L1 expression in EGFR-mutant NSCLC cell lines through the activated PI3K-AKT, MAPK-ERK, and/or JAK-STAT3 pathway [72,73,74,75,76]. This evidence concerns the gene CD274 and non-small cell lung carcinoma.